Rheumatic Heart Disease: Pathogenesis and Vaccine

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
BENTHAM SCIENCE PUBL LTD
Citação
CURRENT PROTEIN & PEPTIDE SCIENCE, v.19, n.9, p.900-908, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Rheumatic fever (RF) and rheumatic heart disease (RHD) follow untreated S. pyogenes throat infections in children who present susceptible genes that favor the development of autoimmune reactions. In this review, we focus on the genes that confer susceptibility and on the autoimmune reactions that occur due to molecular mimicry between human-tissue proteins and streptococcal M protein. Polyarthritis is the initial manifestation, which can evolve to carditis and severe valve damage; these culminate in rheumatic heart disease (RHD) or Sydenham's chorea, which affects the central nervous system. A perspective on vaccine development to prevent the disease is also discussed.
Palavras-chave
Rheumatic fever, rheumatic heart disease, M protein, genes, cytokines, T and B lymphocytes, heart-tissue proteins, anti-S. pyogenes vaccine
Referências
  1. ANASTASIOUNANA MI, 1986, AM HEART J, V112, P992, DOI 10.1016/0002-8703(86)90311-X
  2. Areas GP, 2014, MEM I OSWALDO CRUZ, V109, P935, DOI 10.1590/0074-0276140231
  3. Arya DK, 2014, J INFECT DEV COUNTR, V8, P271, DOI 10.3855/jidc.2874
  4. AYOUB EM, 1986, J CLIN INVEST, V77, P2019, DOI 10.1172/JCI112531
  5. Azevedo PM, 2010, CYTOKINE, V49, P109, DOI 10.1016/j.cyto.2009.09.003
  6. Baroux N, 2014, CLIN INFECT DIS, V59, pE84, DOI 10.1093/cid/ciu490
  7. Bas HD, 2014, J INVEST MED, V62, P78, DOI 10.2310/JIM.0000000000000023
  8. Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800
  9. Berdeli A, 2005, J MOL MED-JMM, V83, P535, DOI 10.1007/s00109-005-0677-x
  10. Berdeli A, 2004, CLIN BIOCHEM, V37, P925, DOI 10.1016/j.clinbiochem.2004.06.007
  11. Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002
  12. Boyd R, 2016, EPIDEMIOL INFECT, V144, P1018, DOI 10.1017/S0950268815002010
  13. CAVELTI PA, 1945, P SOC EXP BIOL MED, V60, P379
  14. Chou HT, 2004, AM HEART J, V148, P181, DOI 10.1016/j.ahj.2004.03.032
  15. Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000
  16. DALE JB, 1995, J INFECT DIS, V171, P1038, DOI 10.1093/infdis/171.4.1038
  17. De Amicis KM, 2014, VACCINE, V32, P4104, DOI 10.1016/j.vaccine.2013.08.043
  18. de Barros SF, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1052-3
  19. Donadi EA, 2000, J NEUROL, V247, P122, DOI 10.1007/s004150070191
  20. Dundar D, 2010, MICROB DRUG RESIST, V16, P279, DOI 10.1089/mdr.2010.0021
  21. Duzgun N, 2009, TISSUE ANTIGENS, V74, P539, DOI 10.1111/j.1399-0039.2009.01347.x
  22. Ellis NMJ, 2005, J IMMUNOL, V175, P5448, DOI 10.4049/jimmunol.175.8.5448
  23. Engel ME, 2014, PEDIATR INFECT DIS J, V33, P208, DOI 10.1097/INF.0b013e3182a5c32a
  24. Espinosa LE, 2003, J CLIN MICROBIOL, V41, P373, DOI 10.1128/JCM.41.1.373-378.2003
  25. Fae K, 2004, MOL IMMUNOL, V40, P1129, DOI 10.1016/j.molimm.2003.11.007
  26. Fae KC, 2006, J IMMUNOL, V176, P5662, DOI 10.4049/jimmunol.176.9.5662
  27. Fae KC, 2013, INFLAMMATION, V36, P800, DOI 10.1007/s10753-013-9606-2
  28. FISCHETTI VA, 1988, J IMMUNOL, V141, P3592
  29. Friaes A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-280
  30. Gu J, 1997, Zhonghua Nei Ke Za Zhi, V36, P308
  31. Guedez Y, 1999, CIRCULATION, V99, P2784
  32. Guerino MT, 2011, VACCINE, V29, P8250, DOI 10.1016/j.vaccine.2011.08.113
  33. Guilherme L, 2006, CLIN DEV IMMUNOL, V13, P125, DOI 10.1080/17402520600877026
  34. Guilherme L, 2006, AUTOIMMUNITY, V39, P31, DOI 10.1080/08916930500484674
  35. GUILHERME L, 1991, CIRCULATION, V83, P1995
  36. Guilherme L, 2004, AM J PATHOL, V165, P1583, DOI 10.1016/S0002-9440(10)63415-3
  37. GUILHERME L, 1995, CIRCULATION, V92, P415
  38. Guilherme L, 2000, INT IMMUNOL, V12, P1063, DOI 10.1093/intimm/12.7.1063
  39. Guilherme L, 2011, J BIOL CHEM, V286, P6989, DOI 10.1074/jbc.M110.132118
  40. Haydardedeoglu FE, 2006, TISSUE ANTIGENS, V68, P293, DOI 10.1111/j.1399-0039.2006.00678.x
  41. Hernandez-Pacheco G, 2003, INT J CARDIOL, V92, P49, DOI 10.1016/S0167-5273(03)00040-8
  42. Hraoui M, 2011, MICROB DRUG RESIST, V17, P377, DOI 10.1089/mdr.2010.0160
  43. Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002
  44. Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x
  45. JHINGHAN B, 1986, TISSUE ANTIGENS, V27, P172
  46. Kamal H, 2010, ACTA CARDIOL, V65, P177, DOI 10.2143/AC.65.2.2047051
  47. Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892
  48. Kirvan CA, 2007, J IMMUNOL, V178, P7412, DOI 10.4049/jimmunol.178.11.7412
  49. Koutouzi F, 2015, J CLIN MICROBIOL, V53, P2015, DOI 10.1128/JCM.00301-15
  50. Koyanagi T, 1996, J MOL CELL CARDIOL, V28, P1349, DOI 10.1006/jmcc.1996.0125
  51. Lopardo HA, 2005, J CLIN MICROBIOL, V43, P802, DOI 10.1128/JCM.43.2.802-807.2005
  52. Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07
  53. Ma Y, 2009, EPIDEMIOL INFECT, V137, P1414, DOI 10.1017/S0950268809002118
  54. MAHARAJ B, 1987, CIRCULATION, V76, P259, DOI 10.1161/01.CIR.76.2.259
  55. Martins CDO, 2014, CLIN MED INSIGHTS-CA, V8, P79, DOI 10.4137/CMC.S17622
  56. McMillan DJ, 2013, CLIN MICROBIOL INFEC, V19, pE222, DOI 10.1111/1469-0691.12134
  57. Meisal R, 2010, J CLIN MICROBIOL, V48, P842, DOI 10.1128/JCM.01312-09
  58. Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x
  59. MONPLAISIR N, 1986, TISSUE ANTIGENS, V28, P209
  60. Mukhopadhyay S, 2013, J HEART VALVE DIS, V22, P118
  61. Murray CJL, 2013, LANCET, V382, P491, DOI 10.1016/S0140-6736(13)61692-X
  62. O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409
  63. O'Grady KAF, 2007, MED J AUSTRALIA, V186, P565
  64. OLMEZ U, 1993, SCAND J RHEUMATOL, V22, P49
  65. OZKAN M, 1993, CIRCULATION, V87, P1974
  66. PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0
  67. Postol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060969
  68. RAJAPAKSE CNA, 1987, BRIT HEART J, V58, P659
  69. Ramasawmy R, 2008, CLIN VACCINE IMMUNOL, V15, P932, DOI 10.1128/CVI.00324-07
  70. Ramasawmy R, 2007, MOL IMMUNOL, V44, P1873, DOI 10.1016/j.molimm.2006.10.001
  71. Rehman S, 2009, IMMUNOL INVEST, V38, P812, DOI 10.3109/08820130903271415
  72. Roberts S, 2001, J INFECT DIS, V183, P507, DOI 10.1086/318076
  73. Rogers S, 2007, J INFECT DIS, V195, P1625, DOI 10.1086/513875
  74. Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260
  75. Schafranski MD, 2008, MOL IMMUNOL, V45, P3827, DOI [10.1016/j.molimm.2008.05.013, 10.1016/j.molinim.2008.05.013]
  76. Seale AC, 2016, EMERG INFECT DIS, V22, P224, DOI 10.3201/eid2202.151358
  77. Settin A, 2007, PEDIATR CARDIOL, V28, P363, DOI 10.1007/s00246-006-0002-7
  78. Shea PR, 2011, EMERG INFECT DIS, V17, P2010, DOI 10.3201/eid1711.110159
  79. Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344
  80. Smeesters PR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000010
  81. Stanevicha V, 2003, ARTHRITIS RES THER, V5, pR340, DOI 10.1186/ar1000
  82. Steer AC, 2008, EPIDEMIOL INFECT, V136, P621, DOI 10.1017/S095026880700917X
  83. Steer AC, 2009, CURR OPIN INFECT DIS, V22, P544, DOI 10.1097/QCO.0b013e328332bbfe
  84. Steer AC, 2009, NAT REV CARDIOL, V6, P689, DOI 10.1038/nrcardio.2009.162
  85. Tamayo E, 2014, J INFECTION, V68, P50, DOI 10.1016/j.jinf.2013.08.013
  86. Tanaka Y, 2016, J INFECT CHEMOTHER, V22, P727, DOI 10.1016/j.jiac.2016.06.013
  87. Tapia MD, 2015, PEDIATR INFECT DIS J, V34, P463, DOI 10.1097/INF.0000000000000608
  88. Tartof SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-327
  89. Visentainer JEL, 2000, J RHEUMATOL, V27, P1518
  90. Wani B A, 1997, Indian Heart J, V49, P152
  91. Williamson DA, 2014, NEW ZEAL MED J, V127, P55